FDA Unanimously Approves 5-11y.o. Vaccinations: “We’re Never Going to Learn About How Safe This Vaccine Is...”

FDA Panel Votes Unanimously to Approve 5-11-year-old Vaccinations: “We’re Never Going to Learn About How Safe This Vaccine Is Unless We Start Giving It, That’s Just The Way It Goes”…

The FDA panel has voted 17 to 0 to approve the Pfizer vaccine for 5 to 11-year-olds.  One of the FDA Panelists, Dr. Ruben, outlined his support by saying “We’re never gonna learn about how safe the vaccine is until we start giving it. That’s the way it goes.” 

Another panelist noted that 700 young people under the age of 18 have died ‘with‘ COVID, or COVID related symptoms in the past two years.  With the full support of the FDA panel, the large scale rollout of the vaccine in young children will now head to the CDC for final approvals. 

WASHINGTON DC – Vaccine advisers to the US Food and Drug Administration voted 17-0 with one abstention Tuesday to recommend Pfizer’s Covid-19 vaccine in children 5 to 11.

Members of the FDA’s Vaccines and Related Biological Products Advisory Committee agreed that the benefits of vaccinating younger children appeared to outweigh the risks, but some members appeared troubled about voting to vaccinate a large population of younger children based on studies of a few thousand.

“It is reassuring to me that we are giving a lower dose,” said Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. Pfizer has cut its vaccine to one-third of the adult dose for the children under 12.

“I am just worried that if we say yes, then the states are going to mandate administration of this vaccine for children to go to school and I do not agree with that,” said Dr. Cody Meissner, a professor of pediatrics at Tufts University School of Medicine. “I think that would be an error at this time.” (read more)

Moderna CEO States Likelihood for Booster Shots Every Year

Moderna Chairman Noubar Afeyan appeared on Fox Business News with Maria Bartiromo earlier today.  [Watch the first four minutes]  As Ms. Bartiromo gleefully congratulates Moderna and Mr. Afeyan for their incredible mRNA technology, the CEO notes there could be a ‘continued need for boosting’ every year.

Watch carefully how Council on Foreign Relations (CFR) member Maria Bartiromo introduces Mr. Noubar Afeyan to her audience at the beginning.

Wall Street very happy…. very happy indeed.

Once you get on the Ronacoaster….